NCT03258840View on ClinicalTrials.gov

EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2013

Study Completion Date

August 31, 2014

Conditions
Diabetes Mellitus Type II
Interventions
DIETARY_SUPPLEMENT

EPA Supplement

EPA supplement, 4 × 500 mg softgel daily (2 g per day), 2 times a day, for 8 weeks.

DIETARY_SUPPLEMENT

EPA Placebo

EPA- placebo softgel (Containing 2 g edible paraffin oil), 4 × 500 mg softgel daily, 2 times a day, for 8 weeks.

Trial Locations (1)

1471613151

Tehran University of Medical Sciences (TUMS), School of Nutritional Sciences and Dietetics, Department of Cellular and Molecular Nutrition, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT03258840 - EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus | Biotech Hunter | Biotech Hunter